Nuvectra (NVTRQ) Stock Price, News & Analysis

Company Overview

Nuvectra Corporation, a neurostimulation medical device company, develops and commercializes neurostimulation technology platform for the treatment of various disorders in neuroscience and clinical markets. The company offers Algovita, a spinal cord stimulation system for the treatment of chronic intractable pain of the trunk and limbs. It is also developing Virtis, a sacral neuromodulation (SNM) system for the treatment of chronic urinary retention and overactive bladder; and technologies to support other indications, including SNM for the treatment of overactive bladder and deep brain stimulation to treat Parkinson's disease. The company serves hospitals, surgery centers, and medical facilities through a direct sales force and third-party distributors in the United States and Europe. Nuvectra Corporation was founded in 2008 and is headquartered in Plano, Texas.

Key Stats

• Today's Range: $0.02 to $0.02
• 50-Day Range: $0.0150 to $0.0150
• 52-Week Range: $0.01 to $4.30
• Volume: 382,600 shs
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

NVTRQ Stock Analysis - Frequently Asked Questions

How have NVTRQ shares performed this year?

Nuvectra's stock was trading at $0.0150 at the beginning of 2025. Since then, NVTRQ shares have increased by 0.0% and is now trading at $0.0150.
View the best growth stocks for 2025 here.

How were Nuvectra's earnings last quarter?

Nuvectra Corp (OTCMKTS:NVTRQ) announced its earnings results on Monday, October, 29th. The company reported ($0.87) EPS for the quarter, missing analysts' consensus estimates of ($0.86) by $0.01. The firm had revenue of $14.22 million for the quarter, compared to the consensus estimate of $12.38 million.

How do I buy shares of Nuvectra?

Shares of NVTRQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

• Last Earnings: 10/29/2018
• Today: 1/15/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Medical Equipment
• Current Symbol: OTCMKTS:NVTRQ
• Previous Symbol: NASDAQ:NVTRV
• CUSIP: N/A
• CIK: 1648893
• Web: www.nuvectramed.com
• Phone: 214-474-3103
• Fax: N/A
• Employees: 197
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A